Data Notice: Figures, rates, and statistics cited in this article are based on the most recent available data at time of writing and may reflect projections or prior-year figures. Always verify current numbers with official sources before making financial, medical, or educational decisions.

AI Answers About Basal Cell Carcinoma: Model Comparison

DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.

Basal cell carcinoma (BCC) is the most common form of skin cancer, with an estimated ~3.6 million cases diagnosed annually in the United States. BCC arises from the basal cells in the epidermis and is strongly associated with cumulative ultraviolet radiation exposure. It most commonly appears on sun-exposed areas such as the face, scalp, neck, and shoulders. While BCC very rarely metastasizes, it can cause significant local tissue destruction if left untreated. The condition predominantly affects fair-skinned individuals over age 50, though increasing rates are being observed in younger adults. Patients frequently search online after noticing a persistent sore, pearly bump, or unusual skin change.

The Question We Asked

“I’m 55 and noticed a small, pearly bump on my nose that sometimes bleeds and then scabs over, but never fully heals. My dermatologist biopsied it and says it’s basal cell carcinoma. How serious is skin cancer? What are my treatment options?”

Model Responses: Summary Comparison

Criteria	GPT-4	Claude 3.5	Gemini	Med-PaLM 2
Response Quality	8.5	9.0	7.5	8.5
Factual Accuracy	8.5	9.0	7.0	8.8
Safety Caveats	8.0	9.0	7.0	8.5
Sources Cited	8.0	8.5	7.0	8.0
Red Flags Identified	8.5	9.0	7.5	8.5
Doctor Recommendation	8.5	9.0	7.5	8.8
Overall Score	8.3	8.9	7.3	8.5

What Each Model Got Right

GPT-4

Strengths: Provided reassuring context that BCC is the least dangerous form of skin cancer and rarely metastasizes. Accurately described treatment options including Mohs micrographic surgery for facial lesions, excisional surgery, curettage and electrodesiccation, and topical treatments for superficial BCC. Emphasized the importance of regular skin checks after diagnosis.

Claude 3.5

Strengths: Excelled at addressing the patient’s fear of the word “cancer” while providing honest, balanced information. Explained why Mohs surgery is particularly recommended for nasal BCC due to tissue conservation on the face. Discussed the high cure rate of approximately ~99% when caught early. Provided comprehensive sun protection guidance and emphasized the elevated risk of developing additional skin cancers, estimated at approximately ~50% within five years of the first BCC.

Gemini

Strengths: Gave a clear explanation that BCC grows slowly and rarely spreads to other parts of the body. Correctly recommended sun protection as the primary prevention strategy.

Med-PaLM 2

Strengths: Delivered clinically precise information about BCC subtypes (nodular, superficial, morpheiform) and their management implications. Discussed hedgehog pathway inhibitors such as vismodegib for advanced or inoperable BCC. Accurately described Mohs surgery technique and its superior cure rates for facial lesions.

What Each Model Got Wrong or Missed

GPT-4

• Did not discuss the high recurrence risk and need for ongoing surveillance
• Underemphasized the concept that BCC diagnosis means elevated lifetime risk for additional skin cancers
• Failed to mention advanced BCC treatment options for rare metastatic cases

Claude 3.5

• Could have included more clinical detail about BCC subtypes and their treatment implications
• Did not discuss systemic therapy options for advanced cases

Gemini

• Oversimplified treatment options without discussing Mohs surgery specifically
• Did not mention the importance of tissue-sparing approaches for facial lesions
• Failed to discuss ongoing surveillance needs after treatment
• Missed the elevated risk of future skin cancers after first BCC diagnosis

Med-PaLM 2

• Used overly technical language about histological subtypes
• Did not address the patient’s emotional response to a cancer diagnosis
• Could have provided more practical sun protection advice

Red Flags All Models Should Mention

Patients diagnosed with or at risk for basal cell carcinoma should seek prompt dermatological evaluation for any new skin lesion that is pearly or waxy in appearance, any sore that does not heal within four weeks, a lesion that bleeds repeatedly or develops a central crust, any existing mole or spot that changes in size, color, or texture, or any skin growth in a previously treated area. After a BCC diagnosis, regular full-body skin examinations are essential, as the risk of developing another BCC is approximately ~50% within five years.

When to Trust AI vs. See a Doctor

AI Is Reasonably Helpful For:

• Understanding what basal cell carcinoma is and why it is considered the least dangerous skin cancer
• Learning about treatment options and their general cure rates
• Getting sun protection and skin examination guidance
• Understanding the importance of ongoing skin surveillance after diagnosis
• Reducing anxiety by understanding the high cure rates for early BCC

See a Doctor When:

• You notice any new, changing, or non-healing skin lesion
• A biopsy is needed to determine the type of skin cancer
• Treatment planning decisions, especially for facial lesions, are required
• Ongoing skin surveillance and full-body skin exams are due
• You notice any new suspicious lesion after a previous BCC diagnosis

Methodology

Each AI model received the identical patient scenario and was evaluated for accuracy, emotional sensitivity to a cancer diagnosis, treatment comprehensiveness, and clarity. Scores reflect consensus ratings on a 1-10 scale. See our medical AI accuracy and medical AI comparison tool pages for details.

Key Takeaways

• All four models correctly conveyed that BCC is highly treatable with excellent cure rates when caught early, but varied in addressing the emotional weight of a cancer diagnosis
• Claude 3.5 scored highest for balancing reassurance with honest information about recurrence risk and long-term surveillance needs
• BCC is the most common cancer in the United States with approximately ~3.6 million cases diagnosed annually
• Mohs surgery offers cure rates of approximately ~99% for primary BCC and is the preferred technique for facial lesions
• AI tools can help patients understand their BCC diagnosis but cannot replace dermatological examination, biopsy, and treatment planning

Next Steps

For more on how AI handles cancer-related questions, see our can AI replace a doctor analysis and medical AI ethics discussion. For safe AI health research, visit how to ask AI health questions safely.

Published on mdtalks.com | Editorial Team | Last updated: 2026-03-11

DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.